FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2410176946> ?p ?o ?g. }

• W2410176946 endingPage "1877" @default.
• W2410176946 startingPage "1877" @default.
• W2410176946 abstract "Erythropoietin ameliorates hyperglycemia in type 1-like diabetic rats Ho-Shan Niu,1 Chin-Hong Chang,2,3 Chiang-Shan Niu,1 Juei-Tang Cheng,3,4 Kung-Shing Lee5–7 1Department of Nursing, Tzu Chi University of Science and Technology, Hualien City, Taiwan, Republic of China; 2Department of Neurosurgery, 3Department of Medical Research, Chi-Mei Medical Center, Yong Kang, Tainan City, Taiwan, Republic of China; 4Institute of Medical Sciences, Chang Jung Christian University, Gueiren, Tainan City, Taiwan, Republic of China; 5Department of Surgery, Division of Neurosurgery, Pingtung Hospital, Pingtung, Taiwan, Republic of China; 6Department of Surgery, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan, Republic of China; 7School of Medicine, Kaohsiung Medical University, Kaohsiung City, Taiwan, Republic of China Background: Erythropoietin (EPO) is widely used in diabetic patients receiving hemodialysis. The role of EPO in glucose homeostasis remains unclear. Therefore, we investigated the effect of EPO on hyperglycemia in rats with type 1-like diabetes.Methods: Rats with streptozotocin-induced type 1-like diabetes (STZ rats) were used to estimate the blood glucose-lowering effects of EPO, and changes in the expression levels of glucose transporter 4 (GLUT4) and the hepatic enzyme phosphoenolpyruvate carboxykinase (PEPCK) were identified by Western blot analysis.Results: EPO attenuated the hyperglycemia in the STZ rats in a dose-dependent manner without altering the hematopoietic parameters, including the hematocrit and number of red blood cells. The involvement of the EPO receptor (EPOR) was identified using EPOR-specific antibodies. In addition, injection of EPO enhanced the glucose utilization, which was assessed using an intravenous glucose tolerance test in rats. However, blood insulin was not changed by EPO in this assay, showing the insulinotropic action of EPO. Moreover, EPO treatment increased the insulin sensitivity. Western blots indicated that the phosphorylation of AMP-activated protein kinase was enhanced by EPO to support the signaling caused by EPOR activation. Furthermore, the decrease in the GLUT4 level in skeletal muscle was reversed by EPO, and the increase in the PEPCK expression in liver was reduced by EPO, as shown in STZ rats.Conclusion: Taken together, the results show that EPO injection may reduce hyperglycemia in diabetic rats through activation of EPO receptors. Therefore, EPO is useful for managing diabetic disorders, particularly hyperglycemia-associated changes. In addition, EPO receptor will be a good target for the development of antihyperglycemic agent(s) in the future. Keywords: erythropoietin, GLUT4, PEPCK, STZ rats" @default.
• W2410176946 created "2016-06-24" @default.
• W2410176946 creator A5015461237 @default.
• W2410176946 creator A5022105093 @default.
• W2410176946 creator A5024020834 @default.
• W2410176946 creator A5057278423 @default.
• W2410176946 creator A5075840812 @default.
• W2410176946 date "2016-06-01" @default.
• W2410176946 modified "2023-09-25" @default.
• W2410176946 title "Erythropoietin ameliorates hyperglycemia in type 1-like diabetic rats" @default.
• W2410176946 cites W1598445442 @default.
• W2410176946 cites W1615595444 @default.
• W2410176946 cites W173650660 @default.
• W2410176946 cites W1814675358 @default.
• W2410176946 cites W1885878334 @default.
• W2410176946 cites W1990370216 @default.
• W2410176946 cites W1994842324 @default.
• W2410176946 cites W2006308023 @default.
• W2410176946 cites W2012461219 @default.
• W2410176946 cites W2019490338 @default.
• W2410176946 cites W2028085666 @default.
• W2410176946 cites W2035326731 @default.
• W2410176946 cites W2052109773 @default.
• W2410176946 cites W2054346918 @default.
• W2410176946 cites W2055334557 @default.
• W2410176946 cites W2056295718 @default.
• W2410176946 cites W2059115670 @default.
• W2410176946 cites W2078089300 @default.
• W2410176946 cites W2079527824 @default.
• W2410176946 cites W2093559498 @default.
• W2410176946 cites W2108712459 @default.
• W2410176946 cites W2109242929 @default.
• W2410176946 cites W2111086157 @default.
• W2410176946 cites W2111691274 @default.
• W2410176946 cites W2115100915 @default.
• W2410176946 cites W2118455831 @default.
• W2410176946 cites W2119304571 @default.
• W2410176946 cites W2126764927 @default.
• W2410176946 cites W2141329138 @default.
• W2410176946 cites W2141708039 @default.
• W2410176946 cites W2153706465 @default.
• W2410176946 cites W2157002396 @default.
• W2410176946 cites W2157824687 @default.
• W2410176946 cites W2170255149 @default.
• W2410176946 cites W2171901801 @default.
• W2410176946 cites W2175922694 @default.
• W2410176946 cites W2184068143 @default.
• W2410176946 cites W2238891163 @default.
• W2410176946 cites W3025393355 @default.
• W2410176946 doi "https://doi.org/10.2147/dddt.s105867" @default.
• W2410176946 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4902144" @default.
• W2410176946 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27350742" @default.
• W2410176946 hasPublicationYear "2016" @default.
• W2410176946 type Work @default.
• W2410176946 sameAs 2410176946 @default.
• W2410176946 citedByCount "7" @default.
• W2410176946 countsByYear W24101769462016 @default.
• W2410176946 countsByYear W24101769462018 @default.
• W2410176946 countsByYear W24101769462019 @default.
• W2410176946 countsByYear W24101769462020 @default.
• W2410176946 countsByYear W24101769462021 @default.
• W2410176946 countsByYear W24101769462022 @default.
• W2410176946 crossrefType "journal-article" @default.
• W2410176946 hasAuthorship W2410176946A5015461237 @default.
• W2410176946 hasAuthorship W2410176946A5022105093 @default.
• W2410176946 hasAuthorship W2410176946A5024020834 @default.
• W2410176946 hasAuthorship W2410176946A5057278423 @default.
• W2410176946 hasAuthorship W2410176946A5075840812 @default.
• W2410176946 hasBestOaLocation W24101769461 @default.
• W2410176946 hasConcept C126322002 @default.
• W2410176946 hasConcept C134018914 @default.
• W2410176946 hasConcept C2778534260 @default.
• W2410176946 hasConcept C31102739 @default.
• W2410176946 hasConcept C555293320 @default.
• W2410176946 hasConcept C556039675 @default.
• W2410176946 hasConcept C71924100 @default.
• W2410176946 hasConceptScore W2410176946C126322002 @default.
• W2410176946 hasConceptScore W2410176946C134018914 @default.
• W2410176946 hasConceptScore W2410176946C2778534260 @default.
• W2410176946 hasConceptScore W2410176946C31102739 @default.
• W2410176946 hasConceptScore W2410176946C555293320 @default.
• W2410176946 hasConceptScore W2410176946C556039675 @default.
• W2410176946 hasConceptScore W2410176946C71924100 @default.
• W2410176946 hasLocation W24101769461 @default.
• W2410176946 hasLocation W24101769462 @default.
• W2410176946 hasLocation W24101769463 @default.
• W2410176946 hasLocation W24101769464 @default.
• W2410176946 hasLocation W24101769465 @default.
• W2410176946 hasOpenAccess W2410176946 @default.
• W2410176946 hasPrimaryLocation W24101769461 @default.
• W2410176946 hasRelatedWork W2016560577 @default.
• W2410176946 hasRelatedWork W2049246778 @default.
• W2410176946 hasRelatedWork W2061080607 @default.
• W2410176946 hasRelatedWork W2064753126 @default.
• W2410176946 hasRelatedWork W2098830437 @default.
• W2410176946 hasRelatedWork W2137584496 @default.
• W2410176946 hasRelatedWork W2167902350 @default.
• W2410176946 hasRelatedWork W2387121292 @default.

• next